Page last updated: 2024-10-25

chlorpromazine and Glycogen Storage Disease

chlorpromazine has been researched along with Glycogen Storage Disease in 1 studies

Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.

Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krovetz, LJ1
McLoughlin, TG1
Schiebler, GL1

Other Studies

1 other study available for chlorpromazine and Glycogen Storage Disease

ArticleYear
Left ventricular function in children studied by increasing peripheral resistance with angiotensin.
    Circulation, 1968, Volume: 37, Issue:5

    Topics: Adolescent; Angiotensin II; Blood Pressure; Cardiac Catheterization; Cardiomegaly; Child; Child, Pre

1968